RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
112 hedge funds and large institutions have $656M invested in Revance Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less capital invested
Capital invested by funds: $734M → $656M (-$77.3M)
Holders
112
Holding in Top 10
2
Calls
$1.14M
Puts
$939K
Top Buyers
| 1 | +$22.6M | |
| 2 | +$17.3M | |
| 3 | +$8.03M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$7.56M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$7.25M |
Top Sellers
| 1 | -$5.68M | |
| 2 | -$3.93M | |
| 3 | -$1.42M | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
-$1.3M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.12M |